InTouch
July / August 2024

Roche Named ISPE 2023 Company of the Year

Marcy Sanford
Roche Named ISPE 2023 Company of the Year

The ISPE International Company of the Year award recognizes outstanding leadership and support provided by a company, as reflected by significant active participation in the Society’s committees, Communities of Practice (CoPs), programs, and activities, as well as its support of employee participation in ISPE. The winner for 2023, Roche, was announced at the 2023 ISPE Annual Meeting & Expo in Las Vegas, Nevada.

Founded in 1896 in Basel, Switzerland, Roche is one of the world’s largest biotechnology companies and a global leader in in-vitro diagnostics. “Roche, including their subsidiaries, was selected due to their strong commitment to employee participation and membership within ISPE,” said Thomas Hartman, President and CEO, ISPE.

“Their engagement with ISPE spans across multiple areas within the Society,” he said. “This includes involvement in ISPE conferences through program committees, speaker participation, Hackathon organization, plus they provide support for their staff to attend. ISPE is grateful for the contributions from Roche.”

In addition to being the pharmaceutical company with the highest number of ISPE members, Roche employees have served as co-chair or chair of guidance document task teams—including the recently published ISPE Baseline® Guide Vol 8: Pharma 4.0™ and the ISPE Guide: Advanced Therapies Medicinal Products: Recombinant AAV Comparability and Lifecycle Management—and served on the program committee for the 2023 ISPE Pharma 4.0™ and Annex 1 Conference.

Long-term involvement in ISPE allows for continued development of technical skills and early involvement in new opportunities to adopt best practices.

Roche employees have served as judges for the ISPE Facility of the Year Awards and are members and leaders of numerous CoPs, including Advanced Pharmaceutical Ingredients (API), Sustainable Facilities, HVAC & Controlled Environments, and GAMP®. They are mentors and participants in ISPE communities such as Women in Pharma®, Emerging Leaders, and the Drug Shortages Initiative Team and have helped with ISPE activities like the annual ISPE Hackathon.

“Our contributions to ISPE Communities of Practice, Chapters, conferences, and global expectations have highlighted the impact we can have as professionals in our industry and our ability to shape the future together—from technical standards all the way to emerging spaces and new modalities,” said Georg Singewald, Head of Roche Pharma Technical Operations Global MSAT, Engineering, and Sustainability.

“Equally as important, we have a lot to learn from our industry partners,” Singewald adds. “Our long-term involvement in ISPE allows for continued development of our technical skills and early involvement in new opportunities to adopt best practices.”